Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP3 | P08254 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1072344 | 0.89 | CA12 (0.36) | ALDH1A1ALDH2LMNACA12CA1 | |
| SCHEMBL492611 | 0.85 | ALDH1A1 (0.33) | ALDH1A1ALDH2LMNACA12CA1 | |
| SCHEMBL11523442 | 0.83 | LMNA (0.39) | ALDH1A1ALDH2LMNACA12CA1 | |
| SCHEMBL1038718 | 0.82 | TDP1 (0.33) | LMNACA12CA1CA9MMP1 | |
| SCHEMBL13119195 | 0.80 | CA12 (0.52) | ALDH1A1ALDH2LMNACA12CA1 | |
| Hydrochloric Acid SCHEMBL10864219 | 0.78 | LMNA (0.32) | LMNACA12CA1CA9MMP1 | |
| SCHEMBL373677 | 0.78 | — | — | |
| SCHEMBL2503822 | 0.75 | LMNA (0.38) | ALDH1A1ALDH2LMNAMMP1MMP2 | |
| Hydrochloric Acid SCHEMBL10861818 | 0.75 | LMNA (0.33) | LMNACA12CA1CA9MMP1 | |
| SCHEMBL1030242 | 0.74 | CA12 (0.38) | ALDH1A1ALDH2LMNACA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3416626-B1 | MICROSPHERES FOR USE IN THERAPEUTIC EMBOLIZATION | BIOSPHERE MEDICAL INC (US) | 2026-02-25 | — | — | EP | claimed |
| EP-4245782-B1 | RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO | BIOSPHERE MEDICAL INC (US) | 2025-10-29 | — | — | EP | claimed |
| EP-4245782-A1 | RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO | BIOSPHERE MEDICAL, INC. (US) | 2023-09-20 | — | — | EP | claimed |
| EP-3660061-B1 | RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO | BIOSPHERE MEDICAL INC (US) | 2023-06-21 | — | — | EP | claimed |
| EP-3245236-B1 | RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO | BIOSPHERE MEDICAL INC (US) | 2020-09-23 | — | — | EP | claimed |
| EP-3660061-A1 | RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO | BIOSPHERE MEDICAL, INC. (US) | 2020-06-03 | — | — | EP | claimed |
| US-20190231908-A1 | RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO | WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT | 2019-08-01 | — | — | US | claimed |
| US-10265423-B2 | Radiopaque monomers, polymers, microspheres, and methods related thereto | BIOSPHERE MEDICAL, INC. (US) | 2019-04-23 | — | — | US | claimed |
| EP-3245236-A1 | RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO | Biosphere Medical Inc. (US) | 2017-11-22 | — | — | EP | claimed |
| WO-2016115023-A1 | RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO | BIOSPHERE MEDICAL, INC. (US) | 2016-07-21 | — | — | WO | claimed |
| US-20160200670-A1 | RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO | WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT | 2016-07-14 | — | — | US | claimed |
| CN-1073467-A | Pressure sensitive adhesive composition and use bonding of the pressure sensitive adhesive etc. of said composition | LINTEC CORP (JP) | 1993-06-23 | — | — | CN | claimed |
| US-4655934-A | BASIC ALUMINUM HALIDE AS FLOCCULANTS TO CLARIFY WATER | NALCO CHEMICAL COMPANY (US) | 1987-04-07 | — | — | US | claimed |
| EP-4245782-B1 | RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO | BIOSPHERE MEDICAL INC (US) | 2025-10-29 | — | — | EP | disclosed |
| US-11926543-B2 | Use of multiple charged ionic compounds derived from polyamines for waste water clarification | ECOLAB USA INC. (US) | 2024-03-12 | — | — | US | disclosed |
| US-11845823-B2 | Radiopaque monomers, polymers, microspheres, and methods related thereto | BIOSPHERE MEDICAL, INC. (US) | 2023-12-19 | — | — | US | disclosed |
| CN-87107768-A | Aqueous dispersions of cationic polymers | — | 1988-06-08 | — | — | CN | disclosed |
| US-4699951-A | MIXTURE OF VINYL HOMOPOLYMER AND, ACRYLAMIDE COPOLYMERIZED WITH VINYL POLYMER | NALCO CHEMICAL COMPANY (US) | 1987-10-13 | — | — | US | disclosed |
| US-4655934-A | BASIC ALUMINUM HALIDE AS FLOCCULANTS TO CLARIFY WATER | NALCO CHEMICAL COMPANY (US) | 1987-04-07 | — | — | US | disclosed |
| US-4588508-A | CATIONIC HOMOPOLYMERS AND COPOLYMERS | NALCO CEHMICAL COMPANY (US) | 1986-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10265423-B2 | Radiopaque monomers, polymers, microspheres, and methods related thereto | CD68, MVD, RAD54L | ALDH1A1 2345/4885ALDH2 3111/4885LMNA 2958/4885 |
| US-11845823-B2 | Radiopaque monomers, polymers, microspheres, and methods related thereto | CD68, MVD, RAD54L | ALDH1A1 2345/4885ALDH2 3111/4885LMNA 2958/4885 |
| US-20190231908-A1 | RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO | CD68, MVD, RAD54L | ALDH1A1 2345/4885ALDH2 3111/4885LMNA 2958/4885 |
| US-20160200670-A1 | RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO | CD68, MVD, RAD54L | ALDH1A1 2345/4885ALDH2 3111/4885LMNA 2958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.